- Home
- Publications
- Publication Search
- Publication Details
Title
Valproic Acid and Breast Cancer: State of the Art in 2021
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 14, Pages 3409
Publisher
MDPI AG
Online
2021-07-08
DOI
10.3390/cancers13143409
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of lipogenesis and induction of apoptosis by valproic acid in prostate cancer cells via the C/EBPα/SREBP-1 pathway
- (2021) B o Pang et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Synergy, Additivity, and Antagonism between Cisplatin and Selected Coumarins in Human Melanoma Cells
- (2021) Paula Wróblewska-Łuczka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Apoptotic effects of valproic acid on miR-34a, miR-520h and HDAC1 gene in breast cancer
- (2021) Nastaran Injinari et al. LIFE SCIENCES
- Regulation of valproic acid induced EMT by AKT/GSK3β/β-catenin signaling pathway in triple negative breast cancer
- (2021) Zeynep Ozman et al. MOLECULAR BIOLOGY REPORTS
- The changing treatment of metastatic her2‑positive breast cancer (Review)
- (2021) Maria Mitsogianni et al. Oncology Letters
- Standard of Care and Promising New Agents for the Treatment of Mesenchymal Triple-Negative Breast Cancer
- (2021) Silvia Mezi et al. Cancers
- EMT‐associated microRNAs and their roles in cancer stemness and drug resistance
- (2021) Guangtao Pan et al. Cancer Communications
- MiRNA-mediated EMT and CSCs in cancer chemoresistance
- (2021) Bing Dong et al. Experimental Hematology & Oncology
- Histone deacetylase 2: A potential therapeutic target for cancer and neurodegenerative disorders
- (2021) Piyush Gediya et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Breast cancer
- (2021) Sibylle Loibl et al. LANCET
- Signaling pathways governing breast cancer stem cells behavior
- (2021) Kai Song et al. Stem Cell Research & Therapy
- The Impact of Non-coding RNAs in the Epithelial to Mesenchymal Transition
- (2021) Bashdar Mahmud Hussen et al. Frontiers in Molecular Biosciences
- The Function of NM23-H1/NME1 and Its Homologs in Major Processes Linked to Metastasis
- (2020) Barbara Mátyási et al. PATHOLOGY & ONCOLOGY RESEARCH
- Efficacy of Panobinostat for the Treatment of Multiple Myeloma
- (2020) Evangelos Eleutherakis-Papaiakovou et al. Journal of Oncology
- Targeting Breast Cancer Cells with G4 PAMAM Dendrimers and Valproic Acid Derivative Complexes
- (2020) Alberto M. Muñoz et al. Anti-Cancer Agents in Medicinal Chemistry
- Synergistic or Additive Pharmacological Interactions between Magnoflorine and Cisplatin in Human Cancer Cells of Different Histological Origin
- (2020) Estera Okon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- OMICS insights into cancer histology; Metabolomics and proteomics approach
- (2020) Akram Tayanloo-Beik et al. CLINICAL BIOCHEMISTRY
- MicroRNAs target the Wnt/β‑catenin signaling pathway to regulate epithelial‑mesenchymal transition in cancer (Review)
- (2020) Yuhe Lei et al. ONCOLOGY REPORTS
- Role of Cadherins in Cancer—A Review
- (2020) Ilona Kaszak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular intrinsic versus clinical subtyping in breast cancer: A comprehensive review
- (2020) Agata Szymiczek et al. CLINICAL GENETICS
- Recent advances in HER2-targeted delivery for cancer therapy
- (2020) Rakesh Kumar Dhritlahre et al. DRUG DISCOVERY TODAY
- MicroRNA 34a–AXL Axis Regulates Vasculogenic Mimicry Formation in Breast Cancer Cells
- (2020) Dansaem Lim et al. Genes
- Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells
- (2019) Anna Wawruszak et al. Cancers
- The basics of epithelial–mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective
- (2019) Vishal Das et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Emerging role of histone deacetylase inhibitors as anti-breast-cancer agents
- (2019) Meran Keshawa Ediriweera et al. DRUG DISCOVERY TODAY
- Sox2: A regulatory factor in tumorigenesis and metastasis
- (2019) Sameer Chaudhary et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Valproic acid exhibits anti-tumor activity selectively against EGFR/ErbB2/ErbB3-coexpressing pancreatic cancer via induction of ErbB family members-targeting microRNAs
- (2019) Tingting Lin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Metabolomics reveals the effect of valproic acid on MCF-7 and MDA-MB-231 cells
- (2019) Xingzhi Zhou et al. XENOBIOTICA
- Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model
- (2019) Claudia Christowitz et al. BMC CANCER
- Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity—An Isobolographic Analysis
- (2019) Anna Wawruszak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immunohistochemistry for diagnosis and prognosis of breast cancer: a review
- (2019) T. Bonacho et al. BIOTECHNIC & HISTOCHEMISTRY
- Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance
- (2019) Monish Ram Makena et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Histone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory properties
- (2019) Anna Wawruszak et al. Cancer Management and Research
- A “NOTCH” Deeper into the Epithelial-To-Mesenchymal Transition (EMT) Program in Breast Cancer
- (2019) Rohan Kar et al. Genes
- Major obstacles to doxorubicin therapy: Cardiotoxicity and drug resistance
- (2019) Hamdan S Al-malky et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Valproic acid promotes the epithelial-to-mesenchymal transition of breast cancer cells through stabilization of Snail and transcriptional upregulation of Zeb1
- (2019) Siyuan Zhang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Role of Capecitabine in Early Breast Cancer
- (2019) Asya N. Varshavsky-Yanovsky et al. JOURNAL OF CLINICAL ONCOLOGY
- Diversity and functional evolution of the plasminogen activator system
- (2018) Rishi Kumar Jaiswal et al. BIOMEDICINE & PHARMACOTHERAPY
- Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins
- (2018) Carrie J. Lovitt et al. BMC CANCER
- Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells
- (2018) Nazlıhan Aztopal et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Key Players of Cisplatin Resistance: Towards a Systems Pharmacology Approach
- (2018) Navin Sarin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Histone Acetylation Modifications of Breast Cancer and their Therapeutic Implications
- (2018) Pingping Guo et al. PATHOLOGY & ONCOLOGY RESEARCH
- Superior anticancer activity is demonstrated by total extract of Curcuma longa L. as opposed to individual curcuminoids separated by centrifugal partition chromatography
- (2018) Wirginia Kukula-Koch et al. PHYTOTHERAPY RESEARCH
- Bioinformatics-based interaction analysis of miR-92a-3p and key genes in tamoxifen-resistant breast cancer cells
- (2018) Jinjing Cun et al. BIOMEDICINE & PHARMACOTHERAPY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Valproic acid as an adjunctive therapeutic agent for the treatment of breast cancer
- (2018) Hayley Heers et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- GLOBOCAN 2018: counting the toll of cancer
- (2018) The Lancet LANCET
- Histone deacetylase inhibitors sensitize 5‑fluorouracil‑resistant MDA‑MB‑468 breast cancer cells to 5‑fluorouracil
- (2018) Tetsuya Minegaki et al. Oncology Letters
- Valproic acid and epilepsy: from molecular mechanisms to clinical evidences
- (2018) Michele Romoli et al. Current Neuropharmacology
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial
- (2018) Mette S van Ramshorst et al. LANCET ONCOLOGY
- miR-145-5p Suppresses Breast Cancer Progression by Inhibiting SOX2
- (2018) Wei Tang et al. JOURNAL OF SURGICAL RESEARCH
- Connexin 43 in the development and progression of breast cancer: What's the connection? (Review)
- (2017) Stephanie L. Phillips et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial
- (2017) David Cameron et al. LANCET
- Thymic Epithelial Tumors phenotype relies on miR-145-5p epigenetic regulation
- (2017) Teresa Bellissimo et al. Molecular Cancer
- Triple-negative breast cancer and the potential for targeted therapy
- (2017) Jing-Ru Jhan et al. PHARMACOGENOMICS
- Triple negative breast cancer: the kiss of death
- (2017) Adriana-Andreea Jitariu et al. Oncotarget
- Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study
- (2017) Yue Gong et al. Scientific Reports
- Trastuzumab in the Treatment of Breast Cancer
- (2016) Sofia Maximiano et al. BIODRUGS
- A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy-free approach in HER2-positive metastatic breast cancer: The HAT study (BOOG 2008-2003), a Dutch Breast Cancer Research Group trial
- (2016) Jan C. Drooger et al. CANCER
- EMT, cell plasticity and metastasis
- (2016) Christine L. Chaffer et al. CANCER AND METASTASIS REVIEWS
- Molecular dissection of valproic acid effects in acute myeloid leukemia identifies predictive networks
- (2016) Frank G. Rücker et al. Epigenetics
- Histone deacetylase inhibitor reverses multidrug resistance by attenuating the nucleophosmin level through PI3K/Akt pathway in breast cancer
- (2016) SI-YING CHEN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Clinical Diagnosis and Management of Breast Cancer
- (2016) E. S. McDonald et al. JOURNAL OF NUCLEAR MEDICINE
- miR-15a/miR-16 induces mitochondrial dependent apoptosis in breast cancer cells by suppressing oncogene BMI1
- (2016) Nibedita Patel et al. LIFE SCIENCES
- Targeted Therapy of Breast Cancer
- (2016) Wolfgang Janni Oncology Research and Treatment
- Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp
- (2015) Khalid O Alfarouk et al. Cancer Cell International
- FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
- (2015) H.-Z. Lee et al. CLINICAL CANCER RESEARCH
- Apoptotic activity of 5-fluorouracil in breast cancer cells transformed by low doses of ionizing α-particle radiation
- (2015) RICHARD PONCE-CUSI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Valproic acid inhibits proliferation of HER2-expressing breast cancer cells by inducing cell cycle arrest and apoptosis through Hsp70 acetylation
- (2015) TOSHIKI MAWATARI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells
- (2015) Shien Hu et al. Molecular Cancer
- miR-520h is crucial for DAPK2 regulation and breast cancer progression
- (2015) C-M Su et al. ONCOGENE
- Romidepsin for the Treatment of Peripheral T-Cell Lymphoma
- (2015) S. P. Iyer et al. ONCOLOGIST
- Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines – An Isobolographic Analysis
- (2015) Anna Wawruszak et al. PLoS One
- HDAC Inhibitors as Novel Anti-Cancer Therapeutics
- (2015) Cristabelle Souza et al. Recent Patents on Anti-Cancer Drug Discovery
- Valproic acid potentiates the anticancer activity of capecitabine in vitro and in vivo in breast cancer models via induction of thymidine phosphorylase expression
- (2015) Manuela Terranova-Barberio et al. Oncotarget
- Breast cancer stem cells, EMT and therapeutic targets
- (2014) Srishti Kotiyal et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Breast tumor subgroups reveal diverse clinical prognostic power
- (2014) Zhaoqi Liu et al. Scientific Reports
- New perspectives of valproic acid in clinical practice
- (2013) Lenka Činčárová et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Sodium valproate inhibits MDA-MB-231 breast cancer cell migration by upregulating NM23H1 expression
- (2012) G.-F. Li et al. GENETICS AND MOLECULAR RESEARCH
- Epigenetic Therapy for Breast Cancer
- (2011) Feng-Feng Cai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A genomic approach to predict synergistic combinations for breast cancer treatment
- (2011) R Soldi et al. PHARMACOGENOMICS JOURNAL
- Molecular and Therapeutic Potential and Toxicity of Valproic Acid
- (2010) Sébastien Chateauvieux et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Valproic Acid Attenuates Blood–Brain Barrier Disruption in a Rat Model of Transient Focal Cerebral Ischemia: The Roles of HDAC and MMP-9 Inhibition
- (2010) Zhifei Wang et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Simultaneous treatment with camptothecin and valproic acid suppresses induction of Bcl-XL and promotes apoptosis of MCF-7 breast cancer cells
- (2009) Yasuhiro Arakawa et al. APOPTOSIS
- Clinical and Biological Effects of Valproic Acid as a Histone Deacetylase Inhibitor on Tumor and Surrogate Tissues: Phase I/II Trial of Valproic acid and Epirubicin/FEC
- (2009) P. Munster et al. CLINICAL CANCER RESEARCH
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- Valproic acid restores ERα and antiestrogen sensitivity to ERα-negative breast cancer cells
- (2009) N. Fortunati et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Subtypes of Breast Cancer Show Preferential Site of Relapse
- (2008) M. Smid et al. CANCER RESEARCH
- Valproic acid as epigenetic cancer drug: Preclinical, clinical and transcriptional effects on solid tumors
- (2008) Alfonso Duenas-Gonzalez et al. CANCER TREATMENT REVIEWS
- Acetylation of non-histone proteins modulates cellular signalling at multiple levels
- (2008) Stephanie Spange et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Valproic acid is a selective antiproliferative agent in estrogen-sensitive breast cancer cells
- (2007) Nicoletta Fortunati et al. CANCER LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search